Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway

Ononin Shows Anticancer Activity Against Laryngeal Cancer via the Inhibition of ERK/JNK/p38 Signaling Pathway

BackgroundLaryngeal cancer is a type of head and neck tumor with a poor prognosis and survival rate. The new cases of laryngeal cancer increased rapidly with a higher mortality rate around the world.ObjectiveThe current research work was focused to unveil the in vitro antitumor effects of ononin aga...

Full description

Bibliographic Details
Main Authors: Ben Ye, Jianhua Ma, Zhaoxia Li, Yang Li, Xiaopan Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
laryngeal cancer
ononin
Hep-2 cells
apoptosis
ERK/JNK/p38 pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.939646/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.939646/full

Similar Items